Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | LIPC | P11150 | 1/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.49 |
| ▸ | ASPH | Q12797 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.46 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17896564 | 0.87 | CES2 (0.58) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL424263 | 0.86 | CES2 (0.78) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL460066 | 0.83 | KDM4E (0.69) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL2856986 | 0.82 | CES2 (0.72) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL2001145 | 0.82 | CES2 (0.72) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL937701 | 0.82 | CES2 (0.72) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL31004884 | 0.82 | CES2 (0.72) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL8924033 | 0.82 | RXRA (0.50) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| Syringol SCHEMBL28265263 | 0.81 | CES2 (0.51) | CES2ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL26020665 | 0.81 | CES2 (0.70) | CES2ALDH1A1HPGDKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | claimed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| WO-2005075471-A2 | THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | BIOVITRUM AB (SE) | 2005-08-18 | — | — | WO | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-12551555-B2 | Compositions and methods for potentiating immune activity | KUMQUAT BIOSCIENCES INC. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | disclosed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | disclosed |
| US-11731988-B2 | Method for producing an organic electronic component, and organic electronic component | NOVALED GMBH (DE) | 2023-08-22 | — | — | US | disclosed |
| CN-110774776-B | Method of forming electrically conductive three-dimensional articles | 施乐公司 | 2023-04-04 | — | — | CN | disclosed |
| US-20230044323-A1 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY | KUMQUAT BIOSCIENCES INC. | 2023-02-09 | — | — | US | disclosed |
| EP-4073242-A1 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY | Kumquat Biosciences Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| CN-115103907-A | Compositions and methods for enhancing immune activity | 金橘生物科技公司 | 2022-09-23 | — | — | CN | disclosed |
| EP-3599077-B1 | METHOD OF FORMING CONDUCTIVE THREE-DIMENSIONAL ARTICLES | XEROX CORP (US) | 2022-02-16 | — | — | EP | disclosed |
| US-20220026805-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-01-27 | — | — | US | disclosed |
| EP-3601290-B1 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | SITEONE THERAPEUTICS INC (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-3356370-B1 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | SITEONE THERAPEUTICS INC (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20210198285-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | NOVALED GMBH (DE) | 2021-07-01 | — | — | US | disclosed |
| US-11040988-B2 | Method for producing an organic electronic component, and organic electronic component | NOVALED GMBH (DE) | 2021-06-22 | — | — | US | disclosed |
| WO-2021119554-A1 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY | KUMQUAT BIOSCIENCES INC. (US) | 2021-06-17 | — | — | WO | disclosed |
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | THE UNIV OF MONTANA (US) | 2021-05-13 | — | — | US | disclosed |
| CN-108440583-B | Boric acid derivative and its medicinal composition | 成都奥璟生物科技有限公司 | 2020-12-04 | — | — | CN | disclosed |
| US-10821658-B2 | Conductive three-dimensional articles | XEROX CORPORATION (US) | 2020-11-03 | — | — | US | disclosed |
| US-20200192220-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2020-06-18 | — | — | US | disclosed |
| EP-3601290-A1 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | Siteone Therapeutics, Inc. (US) | 2020-02-05 | — | — | EP | disclosed |
| US-20200031041-A1 | CONDUCTIVE THREE-DIMENSIONAL ARTICLES | Genesee Valley Innovations, LLC | 2020-01-30 | — | — | US | disclosed |
| EP-3599077-A2 | CONDUCTIVE THREE-DIMENSIONAL ARTICLES | Xerox Corporation (US) | 2020-01-29 | — | — | EP | disclosed |
| EP-3201959-B1 | ORGANIC ELECTRONIC COMPONENT | OSRAM OLED GMBH (DE) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018183782-A1 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | SITEONE THERAPEUTICS, INC. (US) | 2018-10-04 | — | — | WO | disclosed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | disclosed |
| CN-108473503-A | 11, 13-modified saxitoxins for the treatment of pain | 赛特温治疗公司 | 2018-08-31 | — | — | CN | disclosed |
| US-9938422-B2 | Phase change inks comprising crystalline amides | XEROX CORPORATION (US) | 2018-04-10 | — | — | US | disclosed |
| US-9926261-B2 | Bacterial efflux pump inhibitors | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2018-03-27 | — | — | US | disclosed |
| US-9926261-B2 | Bacterial efflux pump inhibitors | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2018-03-27 | — | — | US | disclosed |
| US-9921500-B2 | Fluorinated structured organic film photoreceptor layers | XEROX CORPORATION (US) | 2018-03-20 | — | — | US | disclosed |
| US-20170327516-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | OSRAM OLED GMBH (DE) | 2017-11-16 | — | — | US | disclosed |
| US-20170317288-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | NOVALED GMBH (DE) | 2017-11-02 | — | — | US | disclosed |
| US-9732066-B2 | Heterocyclic derivative and pharmaceutical drug | NIPPON SHINY AKU CO., LTD. (JP) | 2017-08-15 | — | — | US | disclosed |
| CN-102850934-B | Fluorinated structured organic film compositions and manufacture method thereof | 施乐公司 | 2017-05-17 | — | — | CN | disclosed |
| US-9605171-B2 | Solid red ink formulations | XEROX CORPORATION (US) | 2017-03-28 | — | — | US | disclosed |
| US-9580615-B2 | Phase change inks comprising inorganic nucleating agents | XEROX CORPORATION (US) | 2017-02-28 | — | — | US | disclosed |
| US-9528016-B2 | Phase change inks comprising crystalline amides | XEROX CORPORATION (US) | 2016-12-27 | — | — | US | disclosed |
| CN-102911553-B | Comprise the solid-state phase changes ink composite of oxazoline | 施乐公司 | 2016-12-21 | — | — | CN | disclosed |
| US-9523928-B2 | Fluorinated structured organic film photoreceptor layers | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2016-12-20 | — | — | US | disclosed |
| US-9500968-B2 | Addition of non-networked hole transport molecule to fluorinated structured organic film for improved corona resistance | XEROX CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-20160314241-A1 | DRUG DISCOVERY METHOD | Keddem Bioscience Ltd. (IL) | 2016-10-27 | — | — | US | disclosed |
| US-20160314241-A1 | DRUG DISCOVERY METHOD | Keddem Bioscience Ltd. (IL) | 2016-10-27 | — | — | US | disclosed |
| US-20160271082-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160271082-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-09-22 | — | — | US | disclosed |
| US-9447297-B2 | Phase change ink containing amorphous amides | XEROX CORPORATION (US) | 2016-09-20 | — | — | US | disclosed |
| US-9423692-B2 | Composition for forming resist protection film for lithography and method for forming pattern of semiconductor device using the same | DONGJIN SEMICHEM CO., LTD. (KR) | 2016-08-23 | — | — | US | disclosed |
| US-20160231660-A1 | ADDITION OF NON-NETWORKED HOLE TRANSPORT MOLECULE TO FLUORINATED STRUCTURED ORGANIC FILM FOR IMPROVED CORONA RESISTANCE | XEROX CORPORATION | 2016-08-11 | — | — | US | disclosed |
| CN-102807782-B | Solid ink compositions containing hypocrystalline oligomer resin | 施乐公司 | 2016-08-10 | — | — | CN | disclosed |
| US-9405885-B2 | Drug discovery method | Keddem Bioscience Ltd. (IL) | 2016-08-02 | — | — | US | disclosed |
| US-9405885-B2 | Drug discovery method | Keddem Bioscience Ltd. (IL) | 2016-08-02 | — | — | US | disclosed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | disclosed |
| US-9340574-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-05-17 | — | — | US | disclosed |
| WO-2016050330-A1 | METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT, AND ORGANIC ELECTRONIC COMPONENT | OSRAM OLED GMBH (DE) | 2016-04-07 | — | — | WO | disclosed |
| US-20160091805-A1 | FLUORINATED STRUCTURED ORGANIC FILM PHOTORECEPTOR LAYERS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2016-03-31 | — | — | US | disclosed |
| CN-102775851-B | The solid ink of firm solidification and using method thereof | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2016-02-24 | — | — | CN | disclosed |
| US-20160046612-A1 | Heterocyclic Derivative and Pharmaceutical Drug | NIPPON SHINYAKU CO., LTD. (JP) | 2016-02-18 | — | — | US | disclosed |
| CN-102757678-B | Solid ink compositions containing crystal-amorphous mixture | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2016-02-03 | — | — | CN | disclosed |
| US-20160004159-A1 | COMPOSITION FOR FORMING RESIST PROTECTION FILM FOR LITHOGRAPHY AND METHOD FOR FORMING PATTERN OF SEMICONDUCTOR DEVICE USING THE SAME | DONGJIN SEMICHEM CO., LTD. (KR) | 2016-01-07 | — | — | US | disclosed |
| US-9228101-B2 | Rapidly crystallizing phase change inks and methods for forming the same | XEROX CORPORATION (US) | 2016-01-05 | — | — | US | disclosed |
| US-9227922-B2 | Amorphous amides | XEROX CORPORATION (US) | 2016-01-05 | — | — | US | disclosed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-9216968-B2 | Heterocyclic derivative and pharmaceutical drug | NIPPON SHINYAKU CO., LTD. (JP) | 2015-12-22 | — | — | US | disclosed |
| US-9193883-B2 | Phase change ink containing polyester for improved image robustness | XEROX CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| EP-2746265-B1 | HETEROCYCLIC DERIVATIVE AS MICROSOMAL PROSTAGLANDIN E SYNTHASE (mPGEs) INHIBITOR | NIPPON SHINYAKU CO LTD (JP) | 2015-11-18 | — | — | EP | disclosed |
| CN-102757684-B | Bei replaces oxazoline compound or Bei replaces oxazoline derivant | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-11-18 | — | — | CN | disclosed |
| US-9187663-B2 | Ink composition and method of jetting ink | XEROX CORPORATION (US) | 2015-11-17 | — | — | US | disclosed |
| CN-102757679-B | Comprise Bei and replace the ink composite that oxazoline compound or Bei replace oxazoline derivant | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-10-28 | — | — | CN | disclosed |
| US-20150283758-A1 | METHOD OF MAKING THREE-DIMENSIONAL OBJECTS USING CRYSTALLINE AND AMORPHOUS COMPOUNDS | XEROX CORPORATION (US) | 2015-10-08 | — | — | US | disclosed |
| US-20150283759-A1 | METHOD OF MAKING THREE-DIMENSIONAL OBJECTS USING BIO-RENEWABLE CRYSTALLINE-AMORPHOUS MATERIALS | XEROX CORPORATION (US) | 2015-10-08 | — | — | US | disclosed |
| US-9139743-B2 | Malic acid derivatives as amorphous materials for phase change ink | XEROX CORPORATION (US) | 2015-09-22 | — | — | US | disclosed |
| US-9127180-B2 | Phase change inks comprising organic pigments | XEROX CORPORATION (US) | 2015-09-08 | — | — | US | disclosed |
| US-9120943-B2 | Bio-renewable phase change inks | XEROX CORPORATION (US) | 2015-09-01 | — | — | US | disclosed |
| US-20150239931-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-08-27 | — | — | US | disclosed |
| CN-102756556-B | Be separated ink printing method | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-08-19 | — | — | CN | disclosed |
| CN-102757690-B | Be separated ink | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-08-19 | — | — | CN | disclosed |
| US-9109124-B2 | Solid ink compositions comprising semicrystalline oligomer resins | XEROX CORPORATION (US) | 2015-08-18 | — | — | US | disclosed |
| US-9097995-B2 | Electronic devices comprising structured organic films | XEROX CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| US-9096768-B2 | Curable phase change ink compositions | XEROX CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| CN-102086322-B | Comprise the solid ink of the polyhydroxyalkanoatefrom compound for strengthening the property | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2015-07-29 | — | — | CN | disclosed |
| US-9090791-B2 | Mixtures of ester of tartaric acid and ester of citric acid as amorphous materials for phase change inks | XEROX CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| US-9074104-B2 | Inks comprising amorphous ureas | XEROX CORPORATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-9062226-B2 | Compositions of pigment concentrates in phase change inks | XEROX CORPORATION (US) | 2015-06-23 | — | — | US | disclosed |
| US-9056998-B2 | Crystalline compounds for phase change inks | XEROX CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-9051486-B2 | Phase change ink components and methods of making the same | XEROX CORPORATION (US) | 2015-06-09 | — | — | US | disclosed |
| CN-102757680-B | Phase change ink | XEROX CORP | 2015-05-20 | — | — | CN | disclosed |
| CN-102127337-B | A light-cyan solid ink composition and its preparation method | XEROX CORP | 2015-04-29 | — | — | CN | disclosed |
| US-9011587-B1 | Phase change inks comprising novel crystalline compounds | XEROX CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-20150101508-A1 | BIO-RENEWABLE PHASE CHANGE INKS | XEROX CORPORATION (US) | 2015-04-16 | — | — | US | disclosed |
| US-20150105579-A1 | NOVEL CRYSTALLINE COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION (US) | 2015-04-16 | — | — | US | disclosed |
| US-20150105587-A1 | Amorphous Amides | XEROX CORPORATION (US) | 2015-04-16 | — | — | US | disclosed |
| US-20150103122-A1 | Phase Change Ink Containing Amorphous Amides | XEROX CORPORATION (US) | 2015-04-16 | — | — | US | disclosed |
| CN-102153906-B | Curable solid ink compositions | XEROX CORP | 2015-03-25 | — | — | CN | disclosed |
| US-20150080514-A1 | PROTECTIVE OVERCOAT FOR PRINTED IMAGES | XEROX CORPORATION (US) | 2015-03-19 | — | — | US | disclosed |
| US-20150059615-A1 | INKS COMPRISING AMORPHOUS UREAS | XEROX CORPORATION (US) | 2015-03-05 | — | — | US | disclosed |
| US-20150051342-A1 | CURABLE PHASE CHANGE INK COMPOSITIONS | XEROX CORPORATION (US) | 2015-02-19 | — | — | US | disclosed |
| US-8956717-B2 | Clear overcoat compositions and methods for stabilizing the same | XEROX CORPORATION (US) | 2015-02-17 | — | — | US | disclosed |
| US-8952191-B2 | Ester resin compositions | XEROX CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8936359-B2 | Ink compositions incorporating ester resins | XEROX CORPORATION (US) | 2015-01-20 | — | — | US | disclosed |
| CN-102234457-B | Fluorescent ink compositions and fluorescent particles | XEROX CORP | 2014-12-24 | — | — | CN | disclosed |
| US-20140368588-A1 | Phase Change Ink Containing Polyester For Improved Image Robustness | Genesee Valley Innovations, LLC | 2014-12-18 | — | — | US | disclosed |
| US-8911544-B2 | Phase change ink composition | XEROX CORPORATION (US) | 2014-12-16 | — | — | US | disclosed |
| US-8906150-B2 | Phase change inks containing crystalline trans-cinnamic diesters and polyterpene resins | XEROX CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-8906462-B2 | Melt formulation process for preparing structured organic films | XEROX CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140352576-A1 | MIXTURES OF ESTER OF TARTARIC ACID AND ESTER OF CITRIC ACID AS AMORPHOUS MATERIALS FOR PHASE CHANGE INKS | Genesee Valley Innovations, LLC | 2014-12-04 | — | — | US | disclosed |
| US-8901517-B2 | Fluorescent security phase change ink | XEROX CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| EP-2231619-B1 | INHIBITORS OF STEAROYL-COA DESATURASE | HOFFMANN LA ROCHE (CH) | 2014-11-26 | — | — | EP | disclosed |
| US-8888907-B2 | Solid phase change ink compositions comprising oxazolines | XEROX CORPORATION (US) | 2014-11-18 | — | — | US | disclosed |
| US-8882897-B2 | Phase change inks comprising aromatic diester crystalline compounds | XEROX CORPORATION (US) | 2014-11-11 | — | — | US | disclosed |
| US-8859194-B2 | Polymer compound, and resist-protecting film composition including same for a liquid immersion exposure process | DONGJIN SEMICHEM CO., LTD. (KR) | 2014-10-14 | — | — | US | disclosed |
| CN-101914322-B | Pigmented phase change inks with dispersant and synergist | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2014-10-01 | — | — | CN | disclosed |
| CN-101899238-B | Method of making a pigmented phase change ink with dispersant and synergist | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2014-10-01 | — | — | CN | disclosed |
| US-20140285594-A1 | INK COMPOSITION AND METHOD OF JETTING INK | XEROX CORPORATION (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140287205-A1 | Phase Change Ink Composition | XEROX CORPORATION (US) | 2014-09-25 | — | — | US | disclosed |
| US-8840232-B2 | Phase change ink | XEROX CORPORATION (US) | 2014-09-23 | — | — | US | disclosed |
| US-20140272154-A1 | MELT FORMULATION PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2014-09-18 | — | — | US | disclosed |
| US-8827393-B2 | Fluorescent phase change ink compositions | XEROX CORPORATION (US) | 2014-09-09 | — | — | US | disclosed |
| US-8814999-B2 | Phase change ink compositions comprising crystalline sulfone compounds and derivatives thereof | XEROX CORPORATION (US) | 2014-08-26 | — | — | US | disclosed |
| US-8815000-B1 | Solid inks comprising liquid crystalline materials | XEROX CORPORATION (US) | 2014-08-26 | — | — | US | disclosed |
| US-8807697-B2 | Encapsulated reactive ink and method for forming images using same | XEROX CORPORATION (US) | 2014-08-19 | — | — | US | disclosed |
| US-8808438-B2 | Amorphous materials for use in phase change inks | XEROX CORPORATION (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140221339-A1 | Heterocyclic Derivative and Pharmaceutical Drug | NIPPON SHINYAKU CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140208979-A1 | MALIC ACID DERIVATIVES AS AMORPHOUS MATERIALS FOR PHASE CHANGE INK | XEROX CORPORATION (US) | 2014-07-31 | — | — | US | disclosed |
| US-20140204160-A1 | BLANKET MATERIALS FOR INDIRECT PRINTING METHOD COMPRISING STRUCTURED ORGANIC FILMS (SOFS) | XEROX CORPORATION (US) | 2014-07-24 | — | — | US | disclosed |
| US-8784547-B2 | Lightfast solid ink compositions | XEROX CORPORATION (US) | 2014-07-22 | — | — | US | disclosed |
| US-8778069-B2 | Phase change inks containing oligomeric rosin esters | XEROX CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| EP-2746265-A1 | HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL DRUG | Nippon Shinyaku Co., Ltd. (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-8759473-B2 | High mobility periodic structured organic films | XEROX CORPORATION (US) | 2014-06-24 | — | — | US | disclosed |
| US-8753441-B2 | Bio-renewable phase change inks comprising recycled resin materials | XEROX CORPORATION (US) | 2014-06-17 | — | — | US | disclosed |
| US-8747535-B1 | Solid ink compositions comprising crystalline-amorphous mixtures | XEROX CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| US-8747536-B1 | Phase change ink formulation including malic acid derivatives as amorphous materials | XEROX CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| US-8741043-B2 | Bio-renewable fast crystallizing phase change inks | XEROX CORPORATION (US) | 2014-06-03 | — | — | US | disclosed |
| US-8741040-B2 | Phase change ink compositions comprising aromatic ethers | XEROX CORPORATION (US) | 2014-06-03 | — | — | US | disclosed |
| US-8741042-B2 | Phase change inks comprising linear primary alcohols | XEROX CORPORATION (US) | 2014-06-03 | — | — | US | disclosed |
| US-20140147794-A1 | METHOD OF FORMING PHOTORESIST PATTERN | JSR CORPORATION (JP) | 2014-05-29 | — | — | US | disclosed |
| US-20140139591-A1 | INK COMPOSITIONS INCORPORATING ESTER RESINS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140142335-A1 | ESTER RESIN COMPOSITIONS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140142231-A1 | COMPOSITIONS OF PIGMENT CONCENTRATES IN PHASE CHANGE INKS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140137767-A1 | Phase Change Inks Containing Oligomeric Rosin Esters | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140139599-A1 | PHASE CHANGE INKS COMPRISING INORGANIC NUCLEATING AGENTS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140137768-A1 | BIO-RENEWABLE PHASE CHANGE INKS COMPRISING RECYCLED RESIN MATERIALS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140137769-A1 | PIGMENTED MAGENTA AND YELLOW PHASE CHANGE INKS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140128518-A1 | Solid Red Ink Formulations | XEROX CORPORATION (US) | 2014-05-08 | — | — | US | disclosed |
| US-20140118436-A1 | Phase Change Inks Comprising Linear Primary Alcohols | XEROX CORPORATION (US) | 2014-05-01 | — | — | US | disclosed |
| US-8697322-B2 | Imaging members comprising structured organic films | XEROX CORPORATION (US) | 2014-04-15 | — | — | US | disclosed |
| US-8652575-B2 | Ink compositions | XEROX CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-20140045107-A1 | STRUCTURED ORGANIC FILM PHOTORECEPTOR LAYERS CONTAINING FLUORINATED SECONDARY COMPONENTS | XEROX CORPORATION (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140041546-A1 | PHASE CHANGE INK COMPONENTS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2014-02-13 | — | — | US | disclosed |
| US-8647423-B2 | Phase change inks comprising fatty acids | XEROX CORPORATION (US) | 2014-02-11 | — | — | US | disclosed |
| US-8647424-B2 | Phase change inks comprising inorganic nucleating agents | XEROX CORPORATION (US) | 2014-02-11 | — | — | US | disclosed |
| US-20140001377-A1 | FLUORESCENT SECURITY PHASE CHANGE INK | XEROX CORPORATION (US) | 2014-01-02 | — | — | US | disclosed |
| US-20130333591-A1 | LIGHTFAST SOLID INK COMPOSITIONS | XEROX CORPORATION (US) | 2013-12-19 | — | — | US | disclosed |
| US-8591997-B2 | Process for preparing structured organic films (SOFS) via a pre-SOF | XEROX CORPORATION (US) | 2013-11-26 | — | — | US | disclosed |
| US-8591640-B1 | Bio-renewable fast crystallizing phase change inks | XEROX CORPORATION (US) | 2013-11-26 | — | — | US | disclosed |
| US-8586141-B2 | Fluorescent solid ink made with fluorescent nanoparticles | XEROX CORPORATION (US) | 2013-11-19 | — | — | US | disclosed |
| US-20130284058-A1 | PHASE CHANGE INK COMPOSITIONS COMPRISING AROMATIC ETHERS | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130284057-A1 | PHASE CHANGE INKS COMPRISING ORGANIC PIGMENTS | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130284060-A1 | PHASE CHANGE INKS COMPRISING CRYSTALLINE AMIDES | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130284051-A1 | PHASE CHANGE INKS COMPRISING FATTY ACIDS | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130284055-A1 | Rapidly crystallizing phase change inks and methods for forming the same | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130276666-A1 | PHASE CHANGE INK COMPOSITIONS AND SULFONATED COMPOUNDS FOR USE IN THE SAME | XEROX CORPORATION (US) | 2013-10-24 | — | — | US | disclosed |
| US-8551236-B1 | Phase change inks comprising crystalline-amorphous mixtures | XEROX CORPORATION (US) | 2013-10-08 | — | — | US | disclosed |
| US-8544998-B2 | Solid inks containing ketone waxes and branched amides | XEROX CORPORATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-8545612-B1 | Phase change ink compositions and sulfonated compounds for use in the same | XEROX CORPORATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-20130252170-A1 | Polymer Compound, And Resist-Protecting Film Composition Including Same For A Liquid Immersion Exposure Process | DONGJIN SEMICHEM CO., LTD. (KR) | 2013-09-26 | — | — | US | disclosed |
| US-8506694-B2 | Phase separation ink | XEROX CORPORATION (US) | 2013-08-13 | — | — | US | disclosed |
| US-8506040-B2 | Solid ink compositions comprising crystalline-amorphous mixtures | XEROX CORPORATION (US) | 2013-08-13 | — | — | US | disclosed |
| US-8500260-B2 | Ink compositions incorporating substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-8500896-B2 | Solid ink compositions comprising amorphous esters of tartaric acid | XEROX CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-20130183486-A1 | PATTERNED PHOTORECEPTOR OVERCOAT LAYER AND METHODS FOR MAKING THE SAME | XEROX CORPORATION (US) | 2013-07-18 | — | — | US | disclosed |
| US-8481609-B2 | Phase change inks containing oxazoline compounds and polyterpene resins | XEROX CORPORATION (US) | 2013-07-09 | — | — | US | disclosed |
| US-8460844-B2 | Robust photoreceptor surface layer | XEROX CORPORATION (US) | 2013-06-11 | — | — | US | disclosed |
| US-8460447-B2 | Substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-06-11 | — | — | US | disclosed |
| US-20130137033-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2013-05-30 | — | — | US | disclosed |
| US-8449102-B2 | Curable solid inks for raised print applications and methods for using the same | XEROX CORPORATION (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130131226-A1 | Phase Change Inks Containing Crystalline Trans-Cinnamic Diesters and Polyterpene Resins | XEROX CORPORATION (US) | 2013-05-23 | — | — | US | disclosed |
| US-8435718-B2 | Upper layer-forming composition and photoresist patterning method | JSR CORPORATION (JP) | 2013-05-07 | — | — | US | disclosed |
| EP-2581849-A1 | Drug discovery method | KEDDEM BIO-SCIENCE LTD. (IL) | 2013-04-17 | — | — | EP | disclosed |
| US-8410016-B2 | Application of porous structured organic films for gas storage | XEROX CORPORATION (US) | 2013-04-02 | — | — | US | disclosed |
| US-20130078561-A1 | ROBUST PHOTORECEPTOR SURFACE LAYER | XEROX CORPORATION (US) | 2013-03-28 | — | — | US | disclosed |
| US-8389060-B2 | Process for preparing structured organic films (SOFs) via a pre-SOF | XEROX CORPORATION (US) | 2013-03-05 | — | — | US | disclosed |
| US-8377999-B2 | Porous structured organic film compositions | XEROX CORPORATION (US) | 2013-02-19 | — | — | US | disclosed |
| US-8372189-B2 | Phase change inks and methods of making the same | XEROX CORPORATION (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372566-B1 | Fluorinated structured organic film photoreceptor layers | XEROX CORPORATION (US) | 2013-02-12 | — | — | US | disclosed |
| US-20130032057-A1 | SOLID PHASE CHANGE INK COMPOSITIONS COMPRISING OXAZOLINES | XEROX CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| US-20130035428-A1 | Phase Change Inks Containing Oxazoline Compounds and Polyterpene Resins | XEROX CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| US-20130017390-A1 | POROUS STRUCTURED ORGANIC FILM COMPOSITIONS | XEROX CORPORATION (US) | 2013-01-17 | — | — | US | disclosed |
| US-20130017141-A1 | APPLICATION OF POROUS STRUCTURED ORGANIC FILMS FOR GAS STORAGE | XEROX CORPORATION (US) | 2013-01-17 | — | — | US | disclosed |
| US-8353574-B1 | Ink jet faceplate coatings comprising structured organic films | XEROX CORPORATION (US) | 2013-01-15 | — | — | US | disclosed |
| US-20130002764-A1 | INK JET FACEPLATE COATINGS COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2013-01-03 | — | — | US | disclosed |
| US-8342669-B2 | Reactive ink components and methods for forming images using reactive inks | XEROX CORPORATION (US) | 2013-01-01 | — | — | US | disclosed |
| EP-2338935-B1 | FLUORINE-CONTAINING COPOLYMER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | ASAHI GLASS CO LTD (JP) | 2012-12-12 | — | — | EP | disclosed |
| US-20120309896-A1 | SOLID INK COMPOSITIONS COMPRISING SEMICRYSTALLINE OLIGOMER RESINS | XEROX CORPORATION (US) | 2012-12-06 | — | — | US | disclosed |
| US-20120291663-A1 | PHASE CHANGE INK COMPONENTS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-8313560-B1 | Application of porous structured organic films for gas separation | XEROX CORPORATION (US) | 2012-11-20 | — | — | US | disclosed |
| US-8308859-B1 | Phase change ink components and methods of making the same | XEROX CORPORATION (US) | 2012-11-13 | — | — | US | disclosed |
| US-8303832-B2 | Solid inks for masks for printed circuit boards and other electronic devices | PALO ALTO RESEARCH CENTER INCORPORATED (US) | 2012-11-06 | — | — | US | disclosed |
| US-20120272859-A1 | SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272865-A1 | SOLID INK COMPOSITIONS COMPRISING AMORPHOUS ESTERS OF TARTARIC ACID | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274698-A1 | Phase Change Ink | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274699-A1 | SOLID INK COMPOSITIONS COMPRISING CRYSTALLINE-AMORPHOUS MIXTURES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272861-A1 | SOLID INK COMPOSITIONS COMPRISING AMORPHOUS ESTERS OF CITRIC ACID | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274713-A1 | Phase Separation Ink | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272862-A1 | PHASE CHANGE INKS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272860-A1 | PHASE CHANGE INK COMPONENTS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274716-A1 | Print Process For Phase Separation Ink | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274710-A1 | INK COMPOSITIONS INCORPORATING SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120264040-A1 | CLEAR OVERCOAT COMPOSITIONS AND METHODS FOR STABILIZING THE SAME | XEROX CORPORATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120232308-A1 | HIGH MOBILITY PERIODIC STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| US-8247142-B1 | Fluorinated structured organic film compositions | XEROX CORPORATION (US) | 2012-08-21 | — | — | US | disclosed |
| US-8236870-B2 | Curable solid ink compositions | XEROX CORPORATION (US) | 2012-08-07 | — | — | US | disclosed |
| US-20120171613-A1 | UPPER LAYER FILM-FORMING COMPOSITION AND METHOD OF FORMING PHOTORESIST PATTERN | JSR CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| US-8211617-B2 | Solid inks for printed masks | PALO ALTO RESEARCH CENTER INCORPORATED (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120154496-A1 | CURABLE SOLID INKS FOR RAISED PRINT APPLICATIONS AND METHODS FOR USING THE SAME | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120154479-A1 | SOLID INKS CONTAINING KETONE WAXES AND BRANCHED AMIDES | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| EP-1950610-B1 | IMMERSION LITHOGRAPHIC COMPOSITION FOR FORMING UPPER FILM AND METHOD FOR FORMING PHOTORESIST PATTERN | JSR CORP (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | disclosed |
| US-8123848-B2 | Fluorescent ink compositions and fluorescent particles | XEROX CORPORATION (US) | 2012-02-28 | — | — | US | disclosed |
| US-8119315-B1 | Imaging members for ink-based digital printing comprising structured organic films | XEROX CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| US-8119314-B1 | Imaging devices comprising structured organic films | XEROX CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| US-20120040282-A1 | IMAGING DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120040283-A1 | IMAGING MEMBERS FOR INK-BASED DIGITAL PRINTING COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120028176-A1 | IMAGING MEMBERS COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028198-A1 | UPPER LAYER-FORMING COMPOSITION AND PHOTORESIST PATTERNING METHOD | JSR CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-1763350-B1 | NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2011-12-21 | — | — | EP | disclosed |
| US-20110265687-A1 | FLUORESCENT INK COMPOSITIONS AND FLUORESCENT PARTICLES | XEROX CORPORATION (US) | 2011-11-03 | — | — | US | disclosed |
| US-8019550-B2 | Drug discovery method | Keddem Bioscience Ltd. (IL) | 2011-09-13 | — | — | US | disclosed |
| US-8019550-B2 | Drug discovery method | Keddem Bioscience Ltd. (IL) | 2011-09-13 | — | — | US | disclosed |
| US-8002399-B2 | Solid inks incorporating a polyhydroxyalkanoate compound for enhanced properties | XEROX CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110196057-A1 | CURABLE SOLID INK COMPOSITIONS | XEROX CORPORATION (US) | 2011-08-11 | — | — | US | disclosed |
| US-20110177247-A1 | INK COMPOSITIONS | XEROX CORPORATION (US) | 2011-07-21 | — | — | US | disclosed |
| US-20110177245-A1 | INK COMPOSITIONS | XEROX CORPORATION (US) | 2011-07-21 | — | — | US | disclosed |
| US-20110172336-A1 | FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-07-14 | — | — | US | disclosed |
| EP-2338935-A1 | FLUORINE-CONTAINING COPOLYMER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-06-29 | — | — | EP | disclosed |
| US-20110130502-A1 | SOLID INKS INCORPORATING A POLYHYDROXYALKANOATE COMPOUND FOR ENHANCED PROPERTIES | XEROX CORPORATION (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110070372-A1 | Reactive Ink Components And Methods For Forming Images Using Reactive Inks | XEROX CORPORATION (US) | 2011-03-24 | — | — | US | disclosed |
| US-7902330-B2 | Protein kinase inhibitors and methods for identifying same | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2011-03-08 | — | — | US | disclosed |
| US-20110046134-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | BISCHOFF ALEXANDER | 2011-02-24 | — | — | US | disclosed |
| US-20110039193-A1 | SOLID INKS FOR PRINTED MASKS | PALO ALTO RESEARCH CENTER INCORPORATED (US) | 2011-02-17 | — | — | US | disclosed |
| US-20110039194-A1 | SOLID INKS FOR MASKS FOR PRINTED CIRCUIT BOARDS AND OTHER ELECTRONIC DEVICES | PALO ALTO RESEARCH CENTER INCORPORATED (US) | 2011-02-17 | — | — | US | disclosed |
| EP-2266566-A2 | Nicotinamide derivatives and their use as therapeutic agents | Xenon Pharmaceuticals Inc. (CA) | 2010-12-29 | — | — | EP | disclosed |
| US-7842696-B2 | Piperazine derivatives as inhibitors of stearoyl-CoA desaturase | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-11-30 | — | — | US | disclosed |
| EP-1956054-B1 | Phase change ink | XEROX CORP (US) | 2010-11-24 | — | — | EP | disclosed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| US-7807015-B2 | Adhesion promoter | XEROX CORPORATION (US) | 2010-10-05 | — | — | US | disclosed |
| EP-2231619-A1 | INHIBITORS OF STEAROYL-COA DESATURASE | F. Hoffmann-La Roche AG (CH) | 2010-09-29 | — | — | EP | disclosed |
| US-20100227071-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-7780774-B2 | Method of making a pigmented phase change ink with dispersant and synergist | XEROX CORPORATION (US) | 2010-08-24 | — | — | US | disclosed |
| US-7776147-B1 | Pigmented phase change inks with dispersant and synergist | XEROX CORPORATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-20100186624-A1 | METHOD OF MAKING A PIGMENTED PHASE CHANGE INK WITH DISPERSANT AND SYNERGIST | XEROX CORPORATION (US) | 2010-07-29 | — | — | US | disclosed |
| US-7754812-B2 | Adhesion promoter | XEROX CORPORATION (US) | 2010-07-13 | — | — | US | disclosed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-20100112315-A1 | LAMINATING FILM AND METHODS OF USE THEREOF | XEROX CORPORATION (US) | 2010-05-06 | — | — | US | disclosed |
| US-7652013-B2 | Inhibitors of stearoyl-CoA desaturase | HOFFMAN-LA ROCHE INC. (US) | 2010-01-26 | — | — | US | disclosed |
| US-20100003615-A1 | UPPER LAYER-FORMING COMPOSITION AND PHOTORESIST PATTERNING METHOD | JSR CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20090221583-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-03 | — | — | US | disclosed |
| US-20090197894-A1 | NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2009-08-06 | — | — | US | disclosed |
| US-20090197894-A1 | NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2009-08-06 | — | — | US | disclosed |
| WO-2009074487-A1 | INHIBITORS OF STEAROYL-COA DESATURASE | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-18 | — | — | WO | disclosed |
| US-20090149466-A1 | INHIBITORS OF STEAROYL-COA DESATURASE | GILLESPIE PAUL | 2009-06-11 | — | — | US | disclosed |
| WO-2008157844-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2008-12-24 | — | — | WO | disclosed |
| EP-1958993-A1 | Phase change inks containing colorant compounds | Xerox Corporation (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1956054-A2 | Colorant compounds | Xerox Corporation (US) | 2008-08-13 | — | — | EP | disclosed |
| US-20080187664-A1 | Phase change inks containing colorant compounds | XEROX CORPORATION | 2008-08-07 | — | — | US | disclosed |
| US-20080184910-A1 | Mixture of basic dye and wax | XEROX CORPORATION | 2008-08-07 | — | — | US | disclosed |
| EP-1950610-A1 | COMPOSITION FOR FORMING UPPER FILM AND METHOD FOR FORMING PHOTORESIST PATTERN | JSR Corporation (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-7405331-B2 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20080171199-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-07-17 | — | — | US | disclosed |
| US-7390813-B1 | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2008-06-24 | — | — | US | disclosed |
| US-7390813-B1 | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2008-06-24 | — | — | US | disclosed |
| US-7384463-B2 | Phase change ink containing amphiphilic molecule | XEROX CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| US-20080100684-A1 | PHASE CHANGE INK CONTAINING AMPHIPHILIC MOLECULE | XEROX CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |
| US-20080098930-A1 | COLORANT DISPERSANT | XEROX CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |
| US-20080071043-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070254312-A1 | Protein Kinase Inhibitors and Methods for Identiying Same | NATIONAL INSTITUTES OF HEALTH | 2007-11-01 | — | — | US | disclosed |
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | disclosed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | disclosed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | disclosed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | disclosed |
| CN-1724597-A | Phase change inks | XEROX CORP (US) | 2006-01-25 | — | — | CN | disclosed |
| US-20050234090-A1 | Modulators of chemokine receptor activity | PFIZER INC | 2005-10-20 | — | — | US | disclosed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | disclosed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | disclosed |
| EP-1500641-A1 | HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-6821964-B2 | FOR PROPHYLAXIS AND THERAPY OF DISEASES ASSOCIATED WITH MONOCYTE ACCUMULATION, LYMPHOCYTE ACCUMULATION OR LEUCOCYTE ACCUMULATION | PFIZER INC | 2004-11-23 | — | — | US | disclosed |
| EP-0483249-B1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | OSI PHARM INC (US) | 2003-04-23 | — | — | EP | disclosed |
| US-6509393-B2 | Phase change inks | XEROX CORPORATION | 2003-01-21 | — | — | US | disclosed |
| US-20030008893-A1 | Modulators of chemokine receptor activity | COLON-CRUZ ROBERTO (US) | 2003-01-09 | — | — | US | disclosed |
| US-6376175-B1 | CONTACTING CELL WHICH IS CAPABLE OF EXPRESSING GENE WITH AMOUNT OF MOLECULE EFFECTIVE TO TRANSCRIPTIONALLY MODULATE EXPRESSION OF GENE AND THEREBY AFFECT LEVEL OF PROTEIN ENCODED BY GENE WHICH IS EXPRESSED BY CELL | OSI PHARMACEUTICALS, INC. | 2002-04-23 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| US-6203976-B1 | DRUG SCREENING USING EUKARYOTIC CELLS WITH DNA CONSTRUCT OF REGULATORY SEQUENCE AND PROMOTER LINKED TO REPORTER GENE, CONTACTING WITH CHEMICAL, QUANTITATIVELY DETERMINING SIGNAL PRODUCED, COMPARING TO CONTROLS, THEN MIXING WITH CARRIER | OSI PHARMACEUTICALS, INC. | 2001-03-20 | — | — | US | disclosed |
| US-6165712-A | Methods of transcriptionally modulating expression of viral genes and genes useful for production of proteins | OSI PHARMACEUTICALS, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-5976793-A | Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators | ONCOGENE SCIENCE, INC. (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0640588-B1 | Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them | HOECHST AG (DE) | 1999-09-08 | — | — | EP | disclosed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | disclosed |
| US-5665543-A | Method of discovering chemicals capable of functioning as gene expression modulators | ONCOGENE SCIENCE, INC. (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0640588-A1 | Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-03-01 | — | — | EP | disclosed |
| EP-0483249-A4 | — | — | 1994-04-06 | — | — | EP | disclosed |
| WO-1992013092-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING EXPRESSION OF HEMATOPOIETIC GROWTH FACTOR GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| WO-1992012635-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION OF VIRAL GENES AND OTHER GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| WO-1992013063-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING EXPRESSION OF GROWTH FACTOR GENES AND GROWTH FACTOR RECEPTOR GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| EP-0483249-A1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | Oncogene Science, Inc. (US) | 1992-05-06 | — | — | EP | disclosed |
| EP-0472783-A1 | Anti-tumor compositions and compounds | PHARMACHEMIE B.V. (NL) | 1992-03-04 | — | — | EP | disclosed |
| WO-1991001379-A1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | ONCOGENE SCIENCE, INC. (US) | 1991-02-07 | — | — | WO | disclosed |
| WO-1991001379-A1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | ONCOGENE SCIENCE, INC. (US) | 1991-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (31 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130017141-A1 | APPLICATION OF POROUS STRUCTURED ORGANIC FILMS FOR GAS STORAGE | AOX1, ALKBH3, ALKBH2 | CES2 1527/4885ALDH1A1 1292/4885HPGD 3372/4885 |
| US-20120291663-A1 | PHASE CHANGE INK COMPONENTS AND METHODS OF MAKING THE SAME | ALK, TARDBP, MAPT | CES2 1933/4885ALDH1A1 814/4885HPGD 4368/4885 |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | CES2 594/4885ALDH1A1 3087/4885HPGD 3676/4885 |
| US-20070254312-A1 | Protein Kinase Inhibitors and Methods for Identiying Same | PRKCA, PRKCE, PRKCB | CES2 3199/4885ALDH1A1 4408/4885HPGD 3000/4885 |
| US-20140221339-A1 | Heterocyclic Derivative and Pharmaceutical Drug | PTGES, PTGER1, PTGS1 | CES2 4073/4885ALDH1A1 156/4885HPGD 13/4885 |
| US-20090149466-A1 | INHIBITORS OF STEAROYL-COA DESATURASE | SCD, SCD5, FADS2 | CES2 408/4885ALDH1A1 503/4885HPGD 485/4885 |
| US-20110046134-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | SCD, SCD5, FADS2 | CES2 283/4885ALDH1A1 969/4885HPGD 503/4885 |
| US-20170327516-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | OR10J3, AP2M1, OPRM1 | CES2 1028/4885ALDH1A1 510/4885HPGD 3851/4885 |
| US-11040988-B2 | Method for producing an organic electronic component, and organic electronic component | EPCAM, OSTC, L1CAM | CES2 1913/4885ALDH1A1 1817/4885HPGD 3926/4885 |
| US-20160046612-A1 | Heterocyclic Derivative and Pharmaceutical Drug | PTGES, PTGER1, PTGS1 | CES2 4073/4885ALDH1A1 156/4885HPGD 13/4885 |
| US-20140142335-A1 | ESTER RESIN COMPOSITIONS | ELL, ELOB, ELOC | CES2 124/4885ALDH1A1 1359/4885HPGD 859/4885 |
| US-12551555-B2 | Compositions and methods for potentiating immune activity | PTPRCAP, PTPN2, PTPRC | CES2 1242/4885ALDH1A1 4675/4885HPGD 4699/4885 |
| US-11731988-B2 | Method for producing an organic electronic component, and organic electronic component | AP2M1, OR10J3, OPRM1 | CES2 1506/4885ALDH1A1 611/4885HPGD 4285/4885 |
| US-20210198285-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | AP2M1, OR10J3, OPRM1 | CES2 1506/4885ALDH1A1 611/4885HPGD 4285/4885 |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | CES2 594/4885ALDH1A1 3087/4885HPGD 3676/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CES2 1598/4885ALDH1A1 1569/4885HPGD 3145/4885 |
| US-20230044323-A1 | COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE ACTIVITY | NFATC1, MYD88, ICOS | CES2 2307/4885ALDH1A1 4200/4885HPGD 901/4885 |
| US-20150105587-A1 | Amorphous Amides | ALK, ACVR2A, ARG1 | CES2 1217/4885ALDH1A1 1277/4885HPGD 3775/4885 |
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | HBB, AFF4, AFF2 | CES2 2075/4885ALDH1A1 669/4885HPGD 777/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | CES2 2351/4885ALDH1A1 1723/4885HPGD 1878/4885 |
| US-20030008893-A1 | Modulators of chemokine receptor activity | CCR1, CCR3, CCR2 | CES2 1963/4885ALDH1A1 1764/4885HPGD 745/4885 |
| US-20150239931-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTP4A2, PTPRF, PTPA | CES2 1238/4885ALDH1A1 4226/4885HPGD 4820/4885 |
| US-20160271082-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | ABCB11, ABCB1, SLC47A1 | CES2 539/4885ALDH1A1 1019/4885HPGD 251/4885 |
| US-20090221583-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | SCD, SCD5, FADS2 | CES2 283/4885ALDH1A1 969/4885HPGD 503/4885 |
| US-20120232308-A1 | HIGH MOBILITY PERIODIC STRUCTURED ORGANIC FILMS | VIM, PCNA, SMCHD1 | CES2 1959/4885ALDH1A1 2150/4885HPGD 4567/4885 |
| US-20120272859-A1 | SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | CDK7, CDK17, ULK2 | CES2 3688/4885ALDH1A1 2566/4885HPGD 2568/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | CES2 594/4885ALDH1A1 3087/4885HPGD 3676/4885 |
| US-20170317288-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | EPCAM, OSTC, L1CAM | CES2 1913/4885ALDH1A1 1817/4885HPGD 3926/4885 |
| US-20050234090-A1 | Modulators of chemokine receptor activity | CCR3, CCR2, CCR1 | CES2 2057/4885ALDH1A1 1982/4885HPGD 723/4885 |
| US-20090197894-A1 | NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | NAMPT, NNT, NNMT | CES2 2200/4885ALDH1A1 1127/4885HPGD 104/4885 |
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | TREH, STT3B, DDOST | CES2 1587/4885ALDH1A1 3190/4885HPGD 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.